ArticleJournal of experimental & clinical cancer research : CR2018

MYL6B, a myosin light chain, promotes MDM2-mediated p53 degradation and drives HCC development.

Xingwang Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.